{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T11:19:49Z","timestamp":1649071189324},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,7,28]],"date-time":"2010-07-28T00:00:00Z","timestamp":1280275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00296-010-1575-2","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T09:42:01Z","timestamp":1280223721000},"page":"415-417","source":"Crossref","is-referenced-by-count":4,"title":["Can clodronate be effective in the treatment of disabling hydroxyapatite crystal-deposition disease? A report of two cases"],"prefix":"10.1007","volume":"31","author":[{"given":"Gianantonio","family":"Saviola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lul","family":"Abdi-Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Baiardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Benucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,28]]},"reference":[{"key":"1575_CR1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0140-6736(76)91400-8","volume":"1","author":"PA Dieppe","year":"1976","unstructured":"Dieppe PA, Crocker P, Huskisson EC, Willoughby DA (1976) Apatite deposition disease. A new arthropathy. Lancet 1:266\u2013269","journal-title":"Lancet"},{"key":"1575_CR2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1148\/radiology.134.3.6243783","volume":"134","author":"JA Bonavita","year":"1980","unstructured":"Bonavita JA, Dalinka MK, Schumacher HR Jr (1980) Hydroxyapatite deposition disease. Radiology 134:621\u2013625","journal-title":"Radiology"},{"key":"1575_CR3","volume-title":"Rheumatology","author":"GM McCarty","year":"1998","unstructured":"McCarty GM (1998) Crystal related arthropathies. In: Klippel JH, Dieppe PA (eds) Rheumatology, 2nd edn. Mosby, London (section\u00a08)","edition":"2"},{"key":"1575_CR4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-2003-43229","volume":"7","author":"GM Garcia","year":"2003","unstructured":"Garcia GM, McCord GC, Kumar R (2003) Hydroxyapatite crystal deposition disease. Seminar Musculoskelet Radiol 7:187\u2013193","journal-title":"Seminar Musculoskelet Radiol"},{"key":"1575_CR5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02238962","volume":"16","author":"J Pfister","year":"1997","unstructured":"Pfister J, Gerber H (1997) Chronic calcifying tendinitis of the shoulder-therapy by percutaneous needle aspiration and lavage: a prospective open study of 62 shoulders. Clin Rheumatol 16:269\u2013274","journal-title":"Clin Rheumatol"},{"key":"1575_CR6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/er.19.1.80","volume":"19","author":"H Fleisch","year":"1998","unstructured":"Fleisch H (1998) Bisphosphonates: mechanism of action. Endocr Rev 19:80\u2013100","journal-title":"Endocr Rev"},{"key":"1575_CR7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","volume":"38","author":"GH Nancollas","year":"2006","unstructured":"Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W et al (2006) Novel insight into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone 38:617\u2013627","journal-title":"Bone"},{"key":"1575_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1191\/0961203305lu2219oa","volume":"14","author":"M Bevilacqua","year":"2005","unstructured":"Bevilacqua M, Dominguez LJ, Rosini S, Barbagallo M (2005) Bisphosphonates and atherosclerosis: why? Lupus 14:1\u20137","journal-title":"Lupus"},{"key":"1575_CR9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1034\/j.1600-0773.2002.900305.x","volume":"90","author":"R Ylitalo","year":"2002","unstructured":"Ylitalo R, Syvala H, Touhimaa P, Ylitalo P (2002) Suppression of immunoreactive macrophages in atheromatous lesions of rabbits by clodronate. Pharmacol Toxicol 90:139\u2013143","journal-title":"Pharmacol Toxicol"},{"key":"1575_CR10","first-page":"S1 75","volume":"15","author":"N Fujii","year":"2005","unstructured":"Fujii N, Hamano T, Isaka Y, Ito T, Imai E (2005) Risedronate: a possible treatment for extraosseous calcification. Clin Calcium 15:S1 75\u2013S1 78","journal-title":"Clin Calcium"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1575-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-010-1575-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1575-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:18:44Z","timestamp":1559042324000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-010-1575-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,28]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["1575"],"URL":"https:\/\/doi.org\/10.1007\/s00296-010-1575-2","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,28]]}}}